Abstract 329: ApoA-I nanoparticles (CSL-111) Directly Modulates Inflammatory Cells After Myocardial Infarction in Mice

Adèle Richart,Medini Reddy,Alaina K. Natoli,Sarah E. Heywood,Mina Khalaji,Graeme I. Lancaster,Svetlana Diditchenko,Alexei V. Navdaev,Bronwyn A. Kingwell

Abstract 329: ApoA-I nanoparticles (CSL-111) Directly Modulates Inflammatory Cells After Myocardial Infarction in Mice

2019

Adèle Richart
Medini Reddy
Alaina K. Natoli
Sarah E. Heywood
Mina Khalaji
Graeme I. Lancaster
Svetlana Diditchenko
Alexei V. Navdaev
Bronwyn A. Kingwell

Objectives: We have previously shown that apolipoprotein A-I nanoparticles (n-apoAI) delivered immediately after myocardial infarction reduces infarct size and improves heart function in mice. We n...

Keywords:

infarct size
Apolipoprotein B
Internal medicine
Myocardial infarction
Inflammation
Endocrinology
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations